|
|
|
Volumn 93 Suppl 6, Issue , 2010, Pages
|
|
Developing thai economic model to study cost-effectiveness of switching to bupropion compared to combination with bupropion after the failure of an SSRI for major depressive disorder.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
CITALOPRAM;
SEROTONIN UPTAKE INHIBITOR;
ARTICLE;
ASIAN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COMBINATION;
DRUG COST;
DRUG SUBSTITUTION;
ECONOMICS;
HUMAN;
MAJOR DEPRESSION;
OUTPATIENT;
PSYCHOLOGICAL ASPECT;
QUALITY ADJUSTED LIFE YEAR;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL MODEL;
THAILAND;
TREATMENT OUTCOME;
ANTIDEPRESSIVE AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
BUPROPION;
CITALOPRAM;
COST-BENEFIT ANALYSIS;
DEPRESSIVE DISORDER, MAJOR;
DRUG COSTS;
DRUG SUBSTITUTION;
DRUG THERAPY, COMBINATION;
HUMANS;
MODELS, ECONOMIC;
OUTPATIENTS;
QUALITY-ADJUSTED LIFE YEARS;
SEROTONIN UPTAKE INHIBITORS;
THAILAND;
TREATMENT OUTCOME;
|
|
EID: 82555201711
PISSN: 01252208
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
